Fundraising FoxPrincipia Biopharma
South San Francisco, US · Delaware corporation · 10 known investors
Find your way into Principia Biopharma
Sign up to see every warm intro you have to Principia Biopharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Principia Biopharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 10
How we know: Access Biotechnology's portfolio page · Not right? Tell us
How we know: Mission Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: SR One Capital Management's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$65.3M disclosed across 2 of 3 rounds · 2012–2018
- Undisclosed amountSeries AOct 2012
Mission Bay Capital (lead), Morgenthaler Ventures (lead), New Leaf Venture Partners (lead), OrbiMed Advisors (lead), SROne (lead)
Source ↗
▶$50MraisedSep 2018 · 24 investors · BiotechnologyRule 506(b)
- Simeon GeorgeDirector
- Alan ColowickDirector
- Srinivas AkkarajuDirector
- Nassim UsmanDirector
- Peter ThompsonDirector
- Daniel BeckerDirector
- Martin BablerExecutive Officer, Director
- Lewis J. ShusterDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.3MraisedAug 2015 · 13 investors · BiotechnologyRule 506(b)
- MARTIN BABLERExecutive Officer, Director
- PETER THOMPSONDirector
- SRINIVAS AKKARAJUDirector
- LEWIS J. SHUSTERDirector
- MICHAEL DYBBSDirector
- SIMEON GEORGEDirector
- NASSIM USMANDirector
- Offering amount
- $15.3M
- Amount sold
- $15.3M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
5 people who came through Principia Biopharma went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Principia Biopharma's investors?
- Principia Biopharma's investors include Access Biotechnology, Mission Biocapital, Sofinnova Ventures, SR One Capital Management, Mission Bay Capital, New Leaf Venture Partners, OrbiMed, Samsara BioCapital.
- How much funding has Principia Biopharma raised?
- Principia Biopharma has disclosed $65.3M raised across 2 of its 3 known rounds.
- Where is Principia Biopharma headquartered?
- Principia Biopharma is headquartered in South San Francisco, US.